
Sergio Coffa
Examiner (ID: 9524, Phone: (571)270-3022 , Office: P/1675 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658, 1654, 1675 |
| Total Applications | 897 |
| Issued Applications | 440 |
| Pending Applications | 134 |
| Abandoned Applications | 351 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9641877
[patent_doc_number] => 20140219988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'RRECOMBINANT HUMAN SAPOSIN B PROTEIN CONTAINING PHOSPHORYLATED GLUCOSE RING AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/118410
[patent_app_country] => US
[patent_app_date] => 2011-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10694
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118410
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118410 | RRECOMBINANT HUMAN SAPOSIN B PROTEIN CONTAINING PHOSPHORYLATED GLUCOSE RING AND USE THEREOF | Nov 20, 2011 | Abandoned |
Array
(
[id] => 9223528
[patent_doc_number] => 20140018303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => '3-Amino-2-Hydroxy-4-Phenylbutanoyl-Valyl-Isoleucine, Preparation and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/008195
[patent_app_country] => US
[patent_app_date] => 2011-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2057
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008195
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008195 | 3-Amino-2-Hydroxy-4-Phenylbutanoyl-Valyl-Isoleucine, Preparation and Use Thereof | Nov 15, 2011 | Abandoned |
Array
(
[id] => 9192027
[patent_doc_number] => 20130331343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'Materials Presenting Notch Signaling Molecules To Control Cell Behavior'
[patent_app_type] => utility
[patent_app_number] => 13/883005
[patent_app_country] => US
[patent_app_date] => 2011-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2555
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883005
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/883005 | Materials presenting notch signaling molecules to control cell behavior | Nov 7, 2011 | Issued |
Array
(
[id] => 9135515
[patent_doc_number] => 20130296230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'METHOD FOR TREATING MALARIA, METHOD FOR KILLING MALARIA PARASITE, AND USE OF THE METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/881653
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14662
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881653
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/881653 | METHOD FOR TREATING MALARIA, METHOD FOR KILLING MALARIA PARASITE, AND USE OF THE METHODS | Oct 26, 2011 | Abandoned |
Array
(
[id] => 8173526
[patent_doc_number] => 20120108495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'Method of Inhibiting Smooth Muscle Cell Proliferation by Using Reconstituted HDL'
[patent_app_type] => utility
[patent_app_number] => 13/281070
[patent_app_country] => US
[patent_app_date] => 2011-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 2936
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108495.pdf
[firstpage_image] =>[orig_patent_app_number] => 13281070
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/281070 | Method of Inhibiting Smooth Muscle Cell Proliferation by Using Reconstituted HDL | Oct 24, 2011 | Abandoned |
Array
(
[id] => 11225337
[patent_doc_number] => 09453053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Short peptides for enhancing muscle function'
[patent_app_type] => utility
[patent_app_number] => 13/880705
[patent_app_country] => US
[patent_app_date] => 2011-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 27385
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880705
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/880705 | Short peptides for enhancing muscle function | Oct 19, 2011 | Issued |
Array
(
[id] => 10057337
[patent_doc_number] => 09096682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Peptides and uses'
[patent_app_type] => utility
[patent_app_number] => 13/879422
[patent_app_country] => US
[patent_app_date] => 2011-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 10
[patent_no_of_words] => 29215
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879422
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/879422 | Peptides and uses | Oct 16, 2011 | Issued |
Array
(
[id] => 10579806
[patent_doc_number] => 09301917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'Sustained-release pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 13/824598
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 21
[patent_no_of_words] => 13418
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13824598
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/824598 | Sustained-release pharmaceutical composition | Oct 13, 2011 | Issued |
Array
(
[id] => 9964225
[patent_doc_number] => 09011833
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-21
[patent_title] => 'Vitamin E formulations of sulfamide NS3 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/825636
[patent_app_country] => US
[patent_app_date] => 2011-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 45441
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825636
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/825636 | Vitamin E formulations of sulfamide NS3 inhibitors | Oct 6, 2011 | Issued |
Array
(
[id] => 8056033
[patent_doc_number] => 20120077748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'Materials and Methods for Improving Gastrointestinal Function'
[patent_app_type] => utility
[patent_app_number] => 13/245430
[patent_app_country] => US
[patent_app_date] => 2011-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24206
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077748.pdf
[firstpage_image] =>[orig_patent_app_number] => 13245430
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/245430 | Materials and methods for improving gastrointestinal function | Sep 25, 2011 | Issued |
Array
(
[id] => 8160097
[patent_doc_number] => 20120101030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'Caspofungin Composition'
[patent_app_type] => utility
[patent_app_number] => 13/237193
[patent_app_country] => US
[patent_app_date] => 2011-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4091
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101030.pdf
[firstpage_image] =>[orig_patent_app_number] => 13237193
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/237193 | Caspofungin Composition | Sep 19, 2011 | Abandoned |
Array
(
[id] => 8140703
[patent_doc_number] => 20120094897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION'
[patent_app_type] => utility
[patent_app_number] => 13/232815
[patent_app_country] => US
[patent_app_date] => 2011-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29501
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20120094897.pdf
[firstpage_image] =>[orig_patent_app_number] => 13232815
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/232815 | NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION | Sep 13, 2011 | Abandoned |
Array
(
[id] => 7818516
[patent_doc_number] => 20120065136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'RECOMBINANT FACTOR VIII HAVING ENHANCED STABILITY FOLLOWING MUTATION AT THE A1-C2 DOMAIN INTERFACE'
[patent_app_type] => utility
[patent_app_number] => 13/231948
[patent_app_country] => US
[patent_app_date] => 2011-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22163
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065136.pdf
[firstpage_image] =>[orig_patent_app_number] => 13231948
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/231948 | Recombinant factor VIII having enhanced stability following mutation at the A1-C2 domain interface | Sep 12, 2011 | Issued |
Array
(
[id] => 7818517
[patent_doc_number] => 20120065137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'THERAPEUTICS FOR TRAUMA INDUCED FACTOR V CONSUMPTIVE COAGULOPATHY'
[patent_app_type] => utility
[patent_app_number] => 13/225089
[patent_app_country] => US
[patent_app_date] => 2011-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12169
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065137.pdf
[firstpage_image] =>[orig_patent_app_number] => 13225089
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/225089 | THERAPEUTICS FOR TRAUMA INDUCED FACTOR V CONSUMPTIVE COAGULOPATHY | Sep 1, 2011 | Abandoned |
Array
(
[id] => 7791024
[patent_doc_number] => 20120052580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'PEPTIDE-MODIFIED SURFACES FOR CELL CULTURE'
[patent_app_type] => utility
[patent_app_number] => 13/216621
[patent_app_country] => US
[patent_app_date] => 2011-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17791
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20120052580.pdf
[firstpage_image] =>[orig_patent_app_number] => 13216621
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/216621 | PEPTIDE-MODIFIED SURFACES FOR CELL CULTURE | Aug 23, 2011 | Abandoned |
Array
(
[id] => 8927944
[patent_doc_number] => 20130183704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'Labeling Agent and Methods for Simultaneous Sequencing and Quantification of Multiple Peptides and Proteins Using the Same'
[patent_app_type] => utility
[patent_app_number] => 13/818489
[patent_app_country] => US
[patent_app_date] => 2011-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 22894
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818489
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/818489 | Labeling agent and methods for simultaneous sequencing and quantification of multiple peptides and proteins using the same | Aug 22, 2011 | Issued |
Array
(
[id] => 9777678
[patent_doc_number] => 08852882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-07
[patent_title] => 'Biosensors and their use'
[patent_app_type] => utility
[patent_app_number] => 13/817743
[patent_app_country] => US
[patent_app_date] => 2011-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9580
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817743
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/817743 | Biosensors and their use | Aug 15, 2011 | Issued |
Array
(
[id] => 8977313
[patent_doc_number] => 20130210743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'PEPTIDOMIMETIC MACROCYCLES'
[patent_app_type] => utility
[patent_app_number] => 13/816880
[patent_app_country] => US
[patent_app_date] => 2011-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 31186
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816880
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/816880 | Peptidomimetic macrocycles | Aug 12, 2011 | Issued |
Array
(
[id] => 8792864
[patent_doc_number] => 20130109833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'CYCLIC PEPTIDE COMPOUND OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/808772
[patent_app_country] => US
[patent_app_date] => 2011-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13795
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808772
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/808772 | Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same | Jul 5, 2011 | Issued |
Array
(
[id] => 8779600
[patent_doc_number] => 20130101575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'LACTOFERRIN SEQENCES, COMPOSITIONS AND METHODS FOR CORNEAL WOUND TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/806247
[patent_app_country] => US
[patent_app_date] => 2011-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12005
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806247
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/806247 | LACTOFERRIN SEQENCES, COMPOSITIONS AND METHODS FOR CORNEAL WOUND TREATMENT | Jun 30, 2011 | Abandoned |